1Chow AW,Azar RM.Glycopeptides and nephrotoxicity[J].Intensive Care Med,1994,20(Suppl 4):S23-S29.
2Rybak MJ,Abate BJ,Kang SL,et al.Prospective evaluation ofthe effect of an aminoglycoside dosing regimen on rates ofobserved nephrotoxicity and ototoxicity[J].Antimicrob AgentsChemother,1999,43(7):1549-1555.
3Rybak MJ,Albrecht LM,Boike SC,et al.Nephrotoxicityof vancomycin alone and with an aminoglycoside[J].J Anti-microb Chemother,1990,25(4):679-687.
4Wold JS,Turnipseed SA.Toxicity of vancomycin in laboratoryanimals[J].Rev Infect Dis,1981,3(Suppl):S224-S229.
5Zimmermann AE,Katona BG,Plaisance KI.Association ofvancomycin serum concentrations with outcomes in patientswith gram-positive bacteremia[J].Pharmacotherapy,1995,15(1):85-91.
6American Thoracic Society,Infectious Diseases Society ofAmerica.Guidelines for the management of adults with hospital-acquired,ventilator-associated,and healthcare-associated pneu-monia[J].Am J Respir Crit Care Med,2005,171(4):388-416.
